title: Long-term survival in cerebellar glioblastoma multiforme. Case report.
abstract: Primary cerebellar glioblastoma multiforme (GBM) is a rare tumor in adults that accounts for just 1% of all cases of GBM. Cerebellar GBMs are not yet completely understood also as far as the prognosis. We report a case of cerebellar GBM in a 27-year-old woman. Magnetic resonance imaging (MRI) showed a 3x3.6 cm-sized, ill-defined, heterogeneously enhancing mass in the left cerebellum. GBM was histologically confirmed following radical surgery. Postoperative radiotherapy with concomitant and adjuvant temozolomide chemotherapy was subsequently administrated. She has no evidence of recurrence and is in good clinical conditions up-to date, three years after surgery.
authors.affiliation: Cuban Neuroscience Center, Havana, Cuba.
authors.forename: G
authors.initials: G
authors.lastname: Hernandez-Gonzalez
authors.forename: P
authors.initials: P
authors.lastname: Marchione
authors.forename: F
authors.initials: F
authors.lastname: De Angelis
authors.forename: C
authors.initials: C
authors.lastname: Giannone
authors.forename: A
authors.initials: A
authors.lastname: Kouleridou
authors.forename: A
authors.initials: A
authors.lastname: Spallone
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002528:Cerebellar Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D003606:Dacarbazine